| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ENZYME REPLACEMENT THERAPY - GALSULFASE: NAGLAZYME (J1458) RETIRED AS OF 10/8/2020PayerPolicy · BCBSM-2050195 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY FOR SELECT INTRA-ABDOMINAL AND PELVIC MALIGNANCIES - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2195777 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | RECONSTRUCTIVE BREAST SURGERY AND MANAGEMENT OF BREAST IMPLANTS (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210510-0124AB3C06 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PERCUTANEOUS LEFT ATRIAL APPENDAGE CLOSURE DEVICES FOR STROKE PREVENTION IN ATRIAL FIBRILLATIONPayerPolicy · BCBSM-2031298 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INGESTIBLE CAPSULE (E.G., SMARTPILL) FOR ASSESSMENT OF GI (MOTILITY) DISORDERS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2193215 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ENZYME REPLACEMENT THERAPY - AGALSIDASE: FABRAZYME (J0180) RETIRED AS OF 10/8/2020PayerPolicy · BCBSM-2046920 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CARDIAC HEMODYNAMIC MONITORING FOR THE MANAGEMENT OF HEART FAILURE IN THE OUTPATIENT SETTING- MEDICARE ADVANTAGEPayerPolicy · BCBSM-2192862 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING - HUMAN LEUKOCYTE ANTIGEN TESTING FOR CELIAC DISEASE - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198597 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SPINAL SURGERY- MINIMALLY INVASIVE LUMBAR INTERBODY FUSION (LIF) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198289 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GAIT MODULATION AND RHYTHMIC AUDITORY STIMULATION SYSTEM (I.E., INTANDEM) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2199979 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ENDOVENOUS ABLATION FOR THE TREATMENT OF VARICOSE VEINS (E.G., CLARIVEIN, VENASEAL CLOSURE SYSTEM)PayerPolicy · BCBSM-2074456 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | OPTICAL COHERENCE TOMOGRAPHY (OCT) OF THE MIDDLE EAR (E.G., PHOTONICARE CLEARVIEW SYSTEM)PayerPolicy · BCBSM-2090738 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | COMPRESSION PUMPS AND APPLIANCES (E.G., FLECITOUCH? SYSTEM, KOYA DAYSPRING SYSTEM) FOR LYMPHEDEMAPayerPolicy · BCBSM-2097718 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ELECTRORETINOGRAPHY (ERG), MULTIFOCAL ELECTRORETINOGRAPHY (MFERG) AND PATTERN ELECTRORETINOGRAPHY (PERG) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2193210 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ORTHOPTIC TRAINING/VISION THERAPY FOR THE TREATMENT OF VISION OR LEARNING DISABILITIES - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2194065 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING - NGS OF MULTIPLE GENES (PANEL) FOR SOLID AND HEMATOLYMPHOID MALIGNANT CONDITIONSPayerPolicy · BCBSM-2191960 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MYOLYSIS OF UTERINE FIBROIDS USING LAPAROSCOPIC, PERCUTANEOUS, OR TRANSCERVICAL TECHNIQUES - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2193869 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | TREATMENT OF PERIPHERAL NERVE ENTRAPMENT AND CARPAL TUNNEL SYNDROME USING NOVEL METHODSPayerPolicy · BCBSM-2200878 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SACROILIAC JOINT FUSION (PERCUTANEOUS OR MINIMALLY INVASIVE) FOR THE TREATMENT OF LOW BACK PAINPayerPolicy · BCBSM-2039209 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | DRUG TESTING IN PAIN MANAGEMENT AND SUBSTANCE USE DISORDER TREATMENT - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2195978 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | RADIOFREQUENCY ABLATION OF MISCELLANEOUS SOLID TUMORS, EXCLUDING LIVER TUMORS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2194667 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PERIPHERAL NERVE INJURY REPAIR USING SYNTHETIC CONDUITS OR PROCESSED NERVE ALLOGRAFTSPayerPolicy · BCBSM-2199535 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BONE MARROW/HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR MISCELLANEOUS SOLID TUMORS IN ADULTSPayerPolicy · BCBSM-2019829-5ED265FE92 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ENZYME REPLACEMENT THERAPY - LARONIDASE: ALDURAZYME (J1931) retired as of 10/8/2020PayerPolicy · BCBSM-2050193 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PERIRECTAL SPACER FOR RADIATION THERAPY TREATMENT OF PROSTATE CANCER (SPACEOAR) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2194112 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | COMPUTERIZED 2-LEAD RESTING ELECTROCARDIOGRAM ANALYSIS FOR THE DIAGNOSIS OF CORONARY ARTERY DISEASEPayerPolicy · BCBSM-2008343 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | EXTRACORPOREAL SHOCK WAVE THERAPY FOR TREATMENT OF PLANTAR FASCIITIS AND OTHER MUSCULOSKELETAL DISORDERSPayerPolicy · BCBSM-76817 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CEREZYME (IMIGLUCERASE) ENZYME REPLACEMENT THERAPY (J1786) retired as of 10/8/2020PayerPolicy · BCBSM-2131764 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING - ANALYSIS OF MGMT PROMOTER METHYLATION IN MALIGNANT GLIOMAS- MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198885-004E9F086D | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PROTEOMIC TESTING FOR NON-SMALL-CELL LUNG CANCER (NSCLC), E.G., VERISTRATPayerPolicy · BCBSM-2037144 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | POSITRON EMISSION TOMOGRAPHY (PET) FOR MISCELLANEOUS APPLICATIONS (NON-CARDIAC, NON-ONCOLOGIC)PayerPolicy · BCBSM-2020489 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PROSTATIC ARTERY EMBOLIZATION (PAE) FOR BENIGN PROSTATIC HYPERTROPHY (BPH) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198279 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PULMONARY ARTERIAL HYPERTENSION PRODUCTS (policy retired as of 10/7/2021 - mlackley)PayerPolicy · BCBSM-2077747 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | 90587 DENGUE VACCINE, QUADRIVALENT, LIVE, 3 DOSE SCHEDULE, FOR SUBCUTANEOUS USE.PayerPolicy · BCBSM-2076393 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | EXTERNAL UPPER LIMB TREMOR STIMULATOR (E.G., CALA ONE, CALA TRIO)PayerPolicy · BCBSM-2163421 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING - JAK2, MPL AND CALR TESTING FOR MYELOPROLIFERATIVE NEOPLASMS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2197262 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ANDEXANET ALFA: ANDEXXA (J3490, J3590, C9041) retired as of 10/8/2020PayerPolicy · BCBSM-2099265 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ENDOSCOPIC TREATMENTS FOR CHRONIC RHINITIS (E.G., CLRIFIX, RHINEAER, NEUROMARK) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2205280 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING MULTICANCER EARLY DETECTION TESTING (E.G., GALLERI) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198599 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BARIATRIC SURGERY (GASTRIC SURGERY FOR MORBID OBESITY) (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209360-F7A33774D8 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | REMOTE ELECTRICAL NEUROMODULATION FOR MIGRAINES (I.E., NERIVIO) (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209358 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | LOW-LEVEL LASER THERAPY AND HIGH-POWER LASER THERAPY - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2197059 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ENZYME REPLACEMENT THERAPY - IDURSULFASE: ELAPRASE (J1743) retired as of 10/8/2020PayerPolicy · BCBSM-2050194 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CLOSURE DEVICES FOR PATENT FORAMEN OVALE AND ATRIAL SEPTAL DEFECTS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2192498 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) FOR THE TREATMENT OF CEREBRAL VASOPASM FOLLOWING SUBARACHNOID HEMORRHAGEPayerPolicy · BCBSM-2022532 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | OPTICAL COHERENCE TOMOGRAPHY (OCT) OF THE BREAST AND/OR AXILLARY LYMPH NODES - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2197632-B364799DE9 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY WITH SELECTIVE NONINVASIVE FRACTIONAL FLOW RESERVE (FFRCT)PayerPolicy · BCBSM-2104017 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CRYOABLATION OF TUMORS LOCATED IN THE KIDNEY, LUNG, BREAST, PANCREAS, OR BONE - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2192626 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | NONINVASIVE TECHNIQUES FOR THE EVALUATION AND MONITORING OF PATIENTS WITH CHRONIC LIVER DISEASE - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198911 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MAGNETIC RESONANCE IMAGING TO MONITOR INTEGRITY OF SILICONE-GEL-FILLED BREAST IMPLANTSPayerPolicy · BCBSM-2031385 | New policy |
|---|